Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 14, 2015; 21(6): 1728-1737
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1728
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1728
Figure 1 Number of inhabitants covered by one gastroenterology centre entitled to administer biological therapy in 9 selected Central and Eastern European countries, 2014.
Population data: Eurostat Statistics Database (2013)[34], total health expenditure per capita (2012): World Bank Databank[26]. BGR: Bulgaria; CZE: Czech Republic; EST: Estonia; HUN: Hungary; LVA: Latvia; LTU: Lithuania; POL: Poland; ROM: Romania; SVK: Slovakia.
- Citation: Rencz F, Péntek M, Bortlik M, Zagorowicz E, Hlavaty T, Śliwczyński A, Diculescu MM, Kupcinskas L, Gecse KB, Gulácsi L, Lakatos PL. Biological therapy in inflammatory bowel diseases: Access in Central and Eastern Europe. World J Gastroenterol 2015; 21(6): 1728-1737
- URL: https://www.wjgnet.com/1007-9327/full/v21/i6/1728.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i6.1728